579 related articles for article (PubMed ID: 20427401)
21. [Colorectal cancer: screening and surveillance in inflammatory bowel diseases - consensus of the working group for inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology].
Angelberger S; Campregher C; Fuchssteiner H; Gasche C; Gröchenig HP; Haas T; Kazemi-Shirazi L; Mayer A; Miehsler W; Platzer R; Reinisch W; Steiner P; Tilg H; Tillinger W; Vogelsang H; Novacek G
Z Gastroenterol; 2013 May; 51(5):450-7. PubMed ID: 23681899
[TBL] [Abstract][Full Text] [Related]
22. Colonoscopy quality assessment.
Fayad NF; Kahi CJ
Gastrointest Endosc Clin N Am; 2015 Apr; 25(2):373-86. PubMed ID: 25839691
[TBL] [Abstract][Full Text] [Related]
23. An evaluation of colonoscopy surveillance guidelines: are we actually adhering to the guidelines?
Walker AS; Nelson DW; Fowler JJ; Causey MW; Quade S; Johnson EK; Maykel JA; Steele SR
Am J Surg; 2013 May; 205(5):618-22; discussion 622. PubMed ID: 23592173
[TBL] [Abstract][Full Text] [Related]
24. Open Access Colonoscopy for Colorectal Cancer Prevention: An Evaluation of Appropriateness and Quality.
Kapila N; Singh H; Kandragunta K; Castro FJ
Dig Dis Sci; 2019 Oct; 64(10):2798-2805. PubMed ID: 30955174
[TBL] [Abstract][Full Text] [Related]
25. The role of endoscopy in inflammatory bowel disease.
Bharadwaj S; Tandon P; Kulkarni G; Rivas J; Charles R
J Dig Dis; 2015 Dec; 16(12):689-98. PubMed ID: 26595156
[TBL] [Abstract][Full Text] [Related]
26. Quality in Colorectal Cancer Screening with Colonoscopy.
Schoenfeld P
Gastrointest Endosc Clin N Am; 2020 Jul; 30(3):541-551. PubMed ID: 32439087
[TBL] [Abstract][Full Text] [Related]
27. Guideline Adherence to Colonoscopic Surveillance Intervals after Polypectomy in Korea: Results from a Nationwide Survey.
Hong S; Suh M; Choi KS; Park B; Cha JM; Kim HS; Jun JK; Han DS
Gut Liver; 2018 Jul; 12(4):426-432. PubMed ID: 29429156
[TBL] [Abstract][Full Text] [Related]
28. A risk-profiling approach for surveillance of inflammatory bowel disease-colorectal carcinoma is more cost-effective: a comparative cost-effectiveness analysis between international guidelines.
Lutgens M; van Oijen M; Mooiweer E; van der Valk M; Vleggaar F; Siersema P; Oldenburg B
Gastrointest Endosc; 2014 Nov; 80(5):842-8. PubMed ID: 25088918
[TBL] [Abstract][Full Text] [Related]
29. Chromoendoscopy for Surveillance in Inflammatory Bowel Disease Does Not Increase Neoplasia Detection Compared With Conventional Colonoscopy With Random Biopsies: Results From a Large Retrospective Study.
Mooiweer E; van der Meulen-de Jong AE; Ponsioen CY; Fidder HH; Siersema PD; Dekker E; Oldenburg B
Am J Gastroenterol; 2015 Jul; 110(7):1014-21. PubMed ID: 25823770
[TBL] [Abstract][Full Text] [Related]
30. Surveillance of patients with inflammatory bowel disease.
Yu JX; East JE; Kaltenbach T
Best Pract Res Clin Gastroenterol; 2016 Dec; 30(6):949-958. PubMed ID: 27938789
[TBL] [Abstract][Full Text] [Related]
31. Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer.
Rex DK; Boland CR; Dominitz JA; Giardiello FM; Johnson DA; Kaltenbach T; Levin TR; Lieberman D; Robertson DJ
Gastroenterology; 2017 Jul; 153(1):307-323. PubMed ID: 28600072
[TBL] [Abstract][Full Text] [Related]
32. Learning to detect flat neoplastic lesions in inflammatory bowel disease.
Lightdale CJ
Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):xiii-xiv. PubMed ID: 24975539
[No Abstract] [Full Text] [Related]
33. Chromoendoscopy for Dysplasia Surveillance in Inflammatory Bowel Disease.
Flynn AD; Valentine JF
Inflamm Bowel Dis; 2018 Jun; 24(7):1440-1452. PubMed ID: 29668929
[TBL] [Abstract][Full Text] [Related]
34. Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme.
Lee TJ; Rutter MD; Blanks RG; Moss SM; Goddard AF; Chilton A; Nickerson C; McNally RJ; Patnick J; Rees CJ
Gut; 2012 Jul; 61(7):1050-7. PubMed ID: 21940723
[TBL] [Abstract][Full Text] [Related]
35. What Can We Do to Optimize Colonoscopy and How Effective Can We Be?
Hancock KS; Mascarenhas R; Lieberman D
Curr Gastroenterol Rep; 2016 Jun; 18(6):27. PubMed ID: 27098814
[TBL] [Abstract][Full Text] [Related]
36. Adenoma detection rate metrics in colorectal cancer surveillance colonoscopy.
Tjaden JM; Hause JA; Berger D; Duveneck SK; Jakate SM; Orkin BA; Hubbard EL; Melson JE
Surg Endosc; 2018 Jul; 32(7):3108-3113. PubMed ID: 29340817
[TBL] [Abstract][Full Text] [Related]
37. Neoplasia yield and colonoscopic workload of surveillance regimes for colorectal cancer in colitis patients: a retrospective study comparing the performance of the updated AGA and BSG guidelines.
Mooiweer E; van der Meulen AE; van Bodegraven AA; Jansen JM; Mahmmod N; Nijsten J; van Oijen MG; Siersema PD; Oldenburg B
Inflamm Bowel Dis; 2013 Nov; 19(12):2603-10. PubMed ID: 24030524
[TBL] [Abstract][Full Text] [Related]
38. Clinical Practice Guideline on Screening for Colorectal Cancer in Individuals With a Family History of Nonhereditary Colorectal Cancer or Adenoma: The Canadian Association of Gastroenterology Banff Consensus.
Leddin D; Lieberman DA; Tse F; Barkun AN; Abou-Setta AM; Marshall JK; Samadder NJ; Singh H; Telford JJ; Tinmouth J; Wilkinson AN; Leontiadis GI
Gastroenterology; 2018 Nov; 155(5):1325-1347.e3. PubMed ID: 30121253
[TBL] [Abstract][Full Text] [Related]
39. Colorectal cancer surveillance in primary sclerosing cholangitis and inflammatory bowel disease.
Tabibian JH; Moradkhani A; Topazian MD
Ann Hepatol; 2015; 14(4):564-6. PubMed ID: 26019046
[No Abstract] [Full Text] [Related]
40. Recommended intervals between screening and surveillance colonoscopies.
Baron TH; Smyrk TC; Rex DK
Mayo Clin Proc; 2013 Aug; 88(8):854-8. PubMed ID: 23910411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
